Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Illumina Ventures is a venture capital firm dedicated to supporting early-stage companies that are transforming the landscape of genomics and precision health. Founded in 2016, the firm operates from the San Francisco Bay Area and has a European office in Dublin, Ireland. With a strong emphasis on innovation, Illumina Ventures partners with entrepreneurs to drive advancements in areas such as gene editing, AI-enabled drug discovery, and sustainable health solutions.
The firm invests primarily in early-stage companies within the genomics and precision health sectors. Key investment areas include life sciences tools, diagnostics, therapeutics, and digital health. Illumina Ventures is particularly interested in innovations related to single-cell analysis, gene editing, and agricultural biotechnology, supporting companies that are poised to make significant impacts in human health.
Notable portfolio companies include: - **Actym Therapeutics**: Focuses on systemic delivery and tumor-specific effects for cancer treatment. - **Alamar Biosciences**: Develops precision proteomics solutions. - **Arbor Biotechnologies**: Works on gene editing technologies. - **Delfi Diagnostics**: Specializes in early cancer detection through liquid biopsy. - **Fluent BioSciences**: Enhances single-cell sequencing efficiency and accessibility. - **Iambic Therapeutics**: Develops AI-discovered therapeutics, recently raised over $100M. - **Redshift Bio**: Measures structural changes in biomolecules. - **Sonothera**: Develops a nonviral gene therapy platform using ultrasound guidance.
To approach Illumina Ventures, founders should send their pitch to info@illuminaventures.com. The firm is particularly interested in innovations in genomics and precision health, so pitches should highlight advancements in these areas.
Illumina Ventures recently led an $8M Series A round for Infinity Bio and supported Iambic Therapeutics in raising over $100M for AI-discovered therapeutics. The firm is actively deploying from its $200M Fund III.
Illumina Ventures invests in Pre Seed, Seed, Series A, and Series B stages.
Founders can pitch Illumina Ventures by emailing info@illuminaventures.com.
Illumina Ventures focuses on biotech, healthcare, AI, and digital health sectors.
The firm typically invests between $1M and $20M.
Illumina Ventures invests primarily in North America and Europe.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.